Abbott Laboratories (NYSE:ABT)

123.38
Delayed Data
As of 4:00pm ET
 +4.04 / +3.39%
Today’s Change
103.13
Today|||52-Week Range
129.70
+12.69%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$208.3B

Company Description

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Contact Information

Abbott Laboratories
100 Abbott Park Road
Abbott Park Illinois 60064-6400
P:(224) 667-6100
Investor Relations:
(847) 935-3456

Employees

Shareholders

Mutual fund holders40.70%
Individual stakeholders4.16%
Other institutional35.34%

Top Executives

Robert B. FordPresident, CEO, Chief Operating Officer & Director
Robert Emmett FunckChief Financial Officer & Executive VP-Finance
Hubert L. AllenSecretary, Executive VP & General Counsel
Karen PetersonTreasurer & Vice President
Gene HuangChief Economist & Vice President